Economic and Humanistic Burden of Osteoarthritis: An Updated Systematic Review of Large Sample Studies.
Xuejing JinWanxian LiangLining ZhangShihuan CaoLujia YangFeng XiePublished in: PharmacoEconomics (2023)
Since 2016, the ranges of direct costs of OA became wider, while the HRQL of patients remained poor. More countries outside the US have published OA-related disease burden using registry databases.